Position in HLN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$24,300,533
+$2,459,637 QoQ
Shares Held
2,604,559
+19.4% QoQ
Ownership
0.059%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#33
of 639 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026STIFEL FINANCIAL CORP holds $141,737,028 across 29 Drug Manufacturers - Specialty & Generic names. HLN ranks #1 (17.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HLN |
Haleon plc
This page
|
2,604,559 | $24,300,533 | |
| 2 | BCRX |
Biocryst Pharmaceuticals Inc
|
1,826,234 | $18,262,340 | |
| 3 | ZTS |
Zoetis Inc.
|
252,429 | $18,139,545 | |
| 4 | VTRS |
Viatris Inc
|
924,858 | $14,686,743 | |
| 5 | TAK |
Takeda Pharmaceutical Co Ltd
|
722,863 | $11,587,493 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
317,401 | $7,811,236 | |
| 7 | HROW |
Harrow, Inc.
|
180,893 | $7,682,525 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
198,546 | $6,726,737 |
All Filings in HLN
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $24,300,533 | 2,604,559 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $21,840,896 | 2,181,908 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $21,322,502 | 2,109,051 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $19,073,322 | 2,126,346 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $20,646,896 | 1,991,022 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $20,197,414 | 1,962,820 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $19,397,660 | 2,033,298 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $20,573,324 | 1,944,549 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $14,127,446 | 1,710,345 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $13,774,129 | 1,622,395 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $9,894,176 | 1,202,209 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $9,648,228 | 1,158,251 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $9,417,994 | 1,123,866 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $7,502,700 | 921,708 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $8,132,456 | 1,016,557 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $6,171,991 | 1,013,464 | Shares | Defined | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||